Equities

Aimei Health Technology Co Ltd

AFJK:NMQ

Aimei Health Technology Co Ltd

Actions
FinancialsOpen End and Miscellaneous Investment Vehicles
  • Price (USD)10.60
  • Today's Change-0.02 / -0.19%
  • Shares traded406.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 25 2024 16:23 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 20232023
OPERATIONS
Net income0.17
Depreciation/depletion--
Non-Cash items(0.2)
Cash taxes paid, supplemental--
Cash interest paid, supplemental--
Changes in working capital0.02
Total cash from operations0
INVESTING
Capital expenditures--
Other investing and cash flow items, total(70)
Total cash from investing(70)
FINANCING
Financing cash flow items70
Total cash dividends paid--
Issuance (retirement) of stock, net0.03
Issuance (retirement) of debt, net--
Total cash from financing70
NET CHANGE IN CASH
Foreign exchange effects--
Net change in cash0.58
Net cash-begin balance/reserved for future use0
Net cash-end balance/reserved for future use0.58
SUPPLEMENTAL INCOME
Depreciation, supplemental--
Cash interest paid, supplemental--
Cash taxes paid, supplemental--
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.